Ignite Creation Date:
2024-05-06 @ 2:25 PM
Last Modification Date:
2024-10-26 @ 1:31 PM
Study NCT ID:
NCT04318223
Status:
UNKNOWN
Last Update Posted:
2020-03-23
First Post:
2019-12-02
Brief Title:
Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK46 Inhibitor in Combination With Hormonal Therapy
Sponsor:
Consorzio Oncotech
Organization:
Consorzio Oncotech
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-16
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-12-02
First Submit QC Date:
March 20 2020
Study First Post Date:
2020-03-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-20
Last Update Post Date:
2020-03-23
Last Update Post Date Type:
ACTUAL